212 related articles for article (PubMed ID: 20966126)
1. XMRV: a new virus in prostate cancer?
Aloia AL; Sfanos KS; Isaacs WB; Zheng Q; Maldarelli F; De Marzo AM; Rein A
Cancer Res; 2010 Dec; 70(24):10028-33. PubMed ID: 20966126
[TBL] [Abstract][Full Text] [Related]
2. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
3. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.
Sakuma T; Hué S; Squillace KA; Tonne JM; Blackburn PR; Ohmine S; Thatava T; Towers GJ; Ikeda Y
Retrovirology; 2011 Mar; 8():23. PubMed ID: 21447170
[TBL] [Abstract][Full Text] [Related]
4. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
5. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
6. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.
Rezaei SD; Hearps AC; Mills J; Pedersen J; Tachedjian G
Virol J; 2013 Jan; 10():20. PubMed ID: 23305518
[TBL] [Abstract][Full Text] [Related]
7. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences.
Oakes B; Tai AK; Cingöz O; Henefield MH; Levine S; Coffin JM; Huber BT
Retrovirology; 2010 Dec; 7():109. PubMed ID: 21171973
[TBL] [Abstract][Full Text] [Related]
8. Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in Spain.
Luczkowiak J; Martínez-Prats L; Sierra O; Fiorante S; Rubio R; Pulido F; Otero JR; Delgado R
J Acquir Immune Defic Syndr; 2012 Feb; 59(2):101-4. PubMed ID: 21963942
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.
Hong P; Li J
Virus Res; 2012 Jul; 167(1):1-7. PubMed ID: 22531412
[TBL] [Abstract][Full Text] [Related]
10. No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
Switzer WM; Jia H; Zheng H; Tang S; Heneine W
PLoS One; 2011 May; 6(5):e19065. PubMed ID: 21573232
[TBL] [Abstract][Full Text] [Related]
11. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients.
Verhaegh GW; de Jong AS; Smit FP; Jannink SA; Melchers WJ; Schalken JA
Prostate; 2011 Mar; 71(4):415-20. PubMed ID: 20878949
[TBL] [Abstract][Full Text] [Related]
13. Mouse DNA contamination in human tissue tested for XMRV.
Robinson MJ; Erlwein OW; Kaye S; Weber J; Cingoz O; Patel A; Walker MM; Kim WJ; Uiprasertkul M; Coffin JM; McClure MO
Retrovirology; 2010 Dec; 7():108. PubMed ID: 21171966
[TBL] [Abstract][Full Text] [Related]
14. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
15. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.
Garson JA; Kellam P; Towers GJ
Retrovirology; 2011 Feb; 8():13. PubMed ID: 21352548
[TBL] [Abstract][Full Text] [Related]
16. XMRV and prostate cancer--a 'final' perspective.
Sfanos KS; Aloia AL; De Marzo AM; Rein A
Nat Rev Urol; 2012 Jan; 9(2):111-8. PubMed ID: 22231291
[TBL] [Abstract][Full Text] [Related]
17. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.
Schlaberg R; Choe DJ; Brown KR; Thaker HM; Singh IR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16351-6. PubMed ID: 19805305
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
19. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.
Hohn O; Krause H; Barbarotto P; Niederstadt L; Beimforde N; Denner J; Miller K; Kurth R; Bannert N
Retrovirology; 2009 Oct; 6():92. PubMed ID: 19835577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]